Register Login
Register to leave comments
  • News bot Aug. 26, 2026, 5:34 p.m.

    📋 REVOLUTION MEDICINES, INC. (RVMDW) - Clinical Trial Update

    Filing Date: 2026-08-26

    Accepted: 2026-08-26 13:33:35

    Event Type: Clinical Trial Update

    Event Details:

    REVOLUTION MEDICINES, INC. (RVMDW) Announces Clinical Trial Update REVOLUTION MEDICINES, INC. (RVMDW) provided an update on its clinical development programs. Clinical Development Highlights: Clinical development progress update.

    🔬 Clinical Development Pipeline (REVOLUTION MEDICINES, INC.):

    Product Type Development Stage Therapeutic Area Source
    Drug: Osimertinib Drug Phase PHASE1 Solid Tumor ClinicalTrials.gov
    daraxonrasib Other Phase PHASE3 Pancreatic Cancer ClinicalTrials.gov
    Nab-paclitaxel Other Phase PHASE3 Pancreatic Cancer ClinicalTrials.gov
    Gemcitabine (GEM) Other Phase PHASE3 Pancreatic Cancer ClinicalTrials.gov
    Irinotecan Other Phase PHASE3 Pancreatic Cancer ClinicalTrials.gov
    5-Fluorouracil Other Phase PHASE3 Pancreatic Cancer ClinicalTrials.gov
    Leucovorin (Calcium Folinate) Other Phase PHASE3 Pancreatic Cancer ClinicalTrials.gov
    Oxaliplatin Other Phase PHASE3 Pancreatic Cancer ClinicalTrials.gov
    Placebo Other Phase PHASE3 Pancreatic Cancer ClinicalTrials.gov
    Zoldonrasib Other Phase PHASE3 Pancreatic Cancer ClinicalTrials.gov
    pemetrexed + cisplatin /carboplatin Other Phase PHASE3 NSCLC ClinicalTrials.gov
    pembrolizumab Other Phase PHASE3 NSCLC ClinicalTrials.gov
    gemcitabine Other Phase PHASE3 Pancreatic Cancer ClinicalTrials.gov
    SNV1521 Other Phase PHASE1 Pancreatic Cancer ClinicalTrials.gov
    docetaxel Other Phase PHASE3 NSCLC (Non-small Cell Lung Cancer) ClinicalTrials.gov
    Elironrasib Other Phase PHASE1 Non-Small Cell Lung Cancer (NSCLC) ClinicalTrials.gov
    Daraxonrasib (Cohort B1 only) Other Phase PHASE1 Advanced Solid Tumors ClinicalTrials.gov
    Carboplatin/Cisplatin + Pemetrexed (Cohort B2 Only) Other Phase PHASE1 Advanced Solid Tumors ClinicalTrials.gov
    cetuximab (Cohort C2 Only) Other Phase PHASE1 Advanced Solid Tumors ClinicalTrials.gov
    Carboplatin/Cisplatin + Pemetrexed (Dose Expansion Only) Other Phase PHASE1 Advanced Solid Tumors ClinicalTrials.gov
    Ivonescimab Other Phase PHASE1 Advanced Solid Tumors ClinicalTrials.gov
    RMC-9805 Other Phase PHASE1 Colorectal Cancer ClinicalTrials.gov
    cetuximab Other Phase PHASE1 Colorectal Cancer ClinicalTrials.gov
    bevacizumab Other Phase PHASE1 Colorectal Cancer ClinicalTrials.gov
    mFOLFIRINOX regimen Other Phase PHASE1 Colorectal Cancer ClinicalTrials.gov
    mFOLFOX6 regimen Other Phase PHASE1 Colorectal Cancer ClinicalTrials.gov
    RMC-6236 Other Phase PHASE1 Colorectal Cancer ClinicalTrials.gov
    RMC-5127 Other Phase PHASE1 Non-small Cell Lung Cancer (NSCLC) ClinicalTrials.gov
    Pemetrexed Other Phase PHASE1 Non-Small Cell Lung Cancer, NSCLC ClinicalTrials.gov
    Carboplatin Other Phase PHASE1 Non-Small Cell Lung Cancer, NSCLC ClinicalTrials.gov
    Cisplatin Other Phase PHASE1 Non-Small Cell Lung Cancer, NSCLC ClinicalTrials.gov
    RMC-6291 Other Phase PHASE1 Non-Small Cell Lung Cancer, NSCLC ClinicalTrials.gov
    leucovorin Other Phase PHASE3 Pancreatic Cancer ClinicalTrials.gov
    Liposomal irinotecan Other Phase PHASE3 Pancreatic Cancer ClinicalTrials.gov
    RMC-5552 Other Phase PHASE1 Glioblastoma ClinicalTrials.gov
    RMC-4630 Other Phase PHASE1 Solid Tumors ClinicalTrials.gov
    Cobimetinib Other Phase PHASE1 Solid Tumor ClinicalTrials.gov
    Sotorasib Other Phase PHASE2 Non-Small Cell Lung Cancer ClinicalTrials.gov

    💼 Business Developments:

    • Partnership: Not available
    • Acquisition
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: REVOLUTION MEDICINES, INC.
    • Ticker Symbol: RVMDW

Search

News categories